PubMed

Neurogenetic interactions and aberrant behavioral co-morbidity of attention deficit hyperactivity disorder (ADHD): dispelling myths.

Comings DE, Chen TJ, Blum K, Mengucci JF, Blum SH, Meshkin B.

Theor Biol Med Model. 2005 Dec 23;2:50. Review.PMID: 16375770 [PubMed - indexed for MEDLINE]Related articlesFree article

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.PMID: 19445548 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults.

Wigal SB.

CNS Drugs. 2009;23 Suppl 1:21-31. doi: 10.2165/00023210-200923000-00004. Review.PMID: 19621975 [PubMed - indexed for MEDLINE]Related articles

Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.

Wu EQ, Birnbaum HG, Zhang HF, Ivanova JI, Yang E, Mallet D.

J Manag Care Pharm. 2007 Sep;13(7):561-9.PMID: 17874862 [PubMed - indexed for MEDLINE]Related articlesFree article

[Meta-analysis of candidate genes in attention-deficit hyperactivity disorder]

Wohl M, Purper-Ouakil D, Mouren MC, Adès J, Gorwood P.

Encephale. 2005 Jul-Aug;31(4 Pt 1):437-47. French. PMID: 16389711 [PubMed - indexed for MEDLINE]Related articles

[ADHD and attachment processes: are they related?]

Franc N, Maury M, Purper-Ouakil D.

Encephale. 2009 Jun;35(3):256-61. Epub 2008 Sep 20. Review. French. PMID: 19540412 [PubMed - indexed for MEDLINE]Related articles

Review: Genetics of attention deficit/hyperactivity disorder.

Wallis D, Russell HF, Muenke M.

J Pediatr Psychol. 2008 Nov-Dec;33(10):1085-99. Epub 2008 Jun 3. Review.PMID: 18522996 [PubMed - indexed for MEDLINE]Related articles

Genome-wide association studies in ADHD.

Franke B, Neale BM, Faraone SV.

Hum Genet. 2009 Jul;126(1):13-50. Epub 2009 Apr 22. Review.PMID: 19384554 [PubMed - indexed for MEDLINE]Related articles

[Neurobiology of attention-deficit hyperactivity disorder]

Renner TJ, Gerlach M, Romanos M, Herrmann M, Reif A, Fallgatter AJ, Lesch KP.

Nervenarzt. 2008 Jul;79(7):771-81. Review. German. PMID: 18553066 [PubMed - indexed for MEDLINE]Related articles

The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.

Najib J.

Clin Ther. 2009 Jan;31(1):142-76. Review.PMID: 19243715 [PubMed - indexed for MEDLINE]Related articles

Quality of life assessment in adult patients with attention-deficit/hyperactivity disorder treated with atomoxetine.

Adler LA, Sutton VK, Moore RJ, Dietrich AP, Reimherr FW, Sangal RB, Saylor KE, Secnik K, Kelsey DK, Allen AJ.

J Clin Psychopharmacol. 2006 Dec;26(6):648-52.PMID: 17110824 [PubMed - indexed for MEDLINE]Related articles

[Atomoxetine (Strattera), an alternative in the treatment of attention-deficit/hyperactivity disorder (ADHD) in children]

Gaillez C, Sorbara F, Perrin E.

Encephale. 2007 Sep;33(4 Pt 1):621-8. French. PMID: 18033153 [PubMed - indexed for MEDLINE]Related articles

[The prevalence of attention-deficit/hyperactivity disorder (ADHD) among children and adolescents in Germany. Initial results from the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)]

Schlack R, Hölling H, Kurth BM, Huss M.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007 May-Jun;50(5-6):827-35. German. PMID: 17514469 [PubMed - indexed for MEDLINE]Related articles

[Attention deficit hyperactivity disorder (ADHD)--molecular and genetic aspects]

Migdalska A, Nawara M, Bal J, Mazurczak T.

Med Wieku Rozwoj. 2006 Jan-Mar;10(1 Pt 2):343-54. Review. Polish. PMID: 17028398 [PubMed - indexed for MEDLINE]Related articles

Intelligence in DSM-IV combined type attention-deficit/hyperactivity disorder is not predicted by either dopamine receptor/transporter genes or other previously identified risk alleles for attention-deficit/hyperactivity disorder.

Sonuga-Barke EJ, Brookes KJ, Buitelaar J, Anney R, Bitsakou P, Baeyens D, Buschgens C, Chen W, Christiansen H, Eisenberg J, Kuntsi J, Manor I, Meliá A, Mulligan A, Rommelse N, Müller UC, Uebel H, Banaschewski T, Ebstein R, Franke B, Gill M, Miranda A, Oades RD, Roeyers H, Rothenberger A, Sergeant J, Steinhausen HC, Thompson M, Taylor E, Asherson P, Faraone SV.

Am J Med Genet B Neuropsychiatr Genet. 2008 Apr 5;147(3):316-9. Erratum in: Am J Med Genet B Neuropsychiatr Genet. 2008 Jul 5;147B(5):670. PMID: 18023044 [PubMed - indexed for MEDLINE]Related articles

Environmental risk factors for attention-deficit hyperactivity disorder.

Banerjee TD, Middleton F, Faraone SV.

Acta Paediatr. 2007 Sep;96(9):1269-74. Review.PMID: 17718779 [PubMed - indexed for MEDLINE]Related articles

Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD).

Oades RD.

Prog Brain Res. 2008;172:543-65. Review.PMID: 18772050 [PubMed - indexed for MEDLINE]Related articles

Gender differences in 2 clinical trials of adults with attention-deficit/hyperactivity disorder: a retrospective data analysis.

Robison RJ, Reimherr FW, Marchant BK, Faraone SV, Adler LA, West SA.

J Clin Psychiatry. 2008 Feb;69(2):213-21.PMID: 18211131 [PubMed - indexed for MEDLINE]Related articles

Attention-deficit/hyperactivity disorder endophenotypes.

Doyle AE, Willcutt EG, Seidman LJ, Biederman J, Chouinard VA, Silva J, Faraone SV.

Biol Psychiatry. 2005 Jun 1;57(11):1324-35. Review.PMID: 15950005 [PubMed - indexed for MEDLINE]Related articles

[Alterations in the pattern of dopaminergic markers in attention-deficit/hyperactivity disorder]

Díaz-Heijtz R, Mulas F, Forssberg H.

Rev Neurol. 2006 Feb 13;42 Suppl 2:S19-23. Review. Spanish. PMID: 16555214 [PubMed - indexed for MEDLINE]Related articlesFree article